Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
Yochai Adir, Marc Humbert, Walid Saliba
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 361-367.e13
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, et al.
International Forum of Allergy & Rhinology (2023) Vol. 13, Iss. 4, pp. 293-859
Open Access | Times Cited: 225
Asthma and COVID-19: an update
Yochai Adir, Walid Saliba, Antoine Beurnier, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210152-210152
Open Access | Times Cited: 89
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
Fan Zou, Chengyu Zhu, Siyu Lou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 29
Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients
Rasoul Abdollahzadeh, Mohammad Hossein Shushizadeh, Mina Barazandehrokh, et al.
Infection Genetics and Evolution (2021) Vol. 96, pp. 105098-105098
Open Access | Times Cited: 45
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review
Jennifer Sasson, G. Brett Moreau, William A. Petri
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 6, pp. 727-732
Open Access | Times Cited: 16
Covid‐19 pandemic and asthma: What did we learn?
Chloë I. Bloom
Respirology (2023) Vol. 28, Iss. 7, pp. 603-614
Open Access | Times Cited: 15
COVID-19 Infections and Asthma
Philip Palmon, Daniel J. Jackson, Loren C. Denlinger
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 3, pp. 658-663
Open Access | Times Cited: 27
Living without eosinophils: evidence from mouse and man
David J. Jackson, Ian Pavord
European Respiratory Journal (2022) Vol. 61, Iss. 1, pp. 2201217-2201217
Open Access | Times Cited: 22
The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
Kaneez Fatima, Talal Almas, Shan Lakhani, et al.
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 3, pp. 37-37
Open Access | Times Cited: 20
Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
Yuka Uruma, Toshie Manabe, Yuji Fujikura, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0276774-e0276774
Open Access | Times Cited: 20
Asthma in the era of COVID-19
Sara Assaf, Henning Stenberg, Miloš Jeseňák, et al.
Respiratory Medicine (2023) Vol. 218, pp. 107373-107373
Open Access | Times Cited: 12
Severe Asthma and Active SARS-CoV-2 Infection: Insights into Biologics
Sara Manti, Michela Leotta, F. D’Amico, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 674-674
Open Access
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
Andriana Ι. Papaioannou, Evangelia Fouka, Νikolaos Tzanakis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2588-2595
Open Access | Times Cited: 17
Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations
Анна Старшинова, Anastasiia A. Borozinets, Anastasia Kulpina, et al.
Pathophysiology (2024) Vol. 31, Iss. 2, pp. 269-287
Open Access | Times Cited: 3
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
Cheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, et al.
Endocrinology and Metabolism (2021) Vol. 36, Iss. 4, pp. 757-765
Open Access | Times Cited: 22
Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients
Axelle Dupont, Camille Couffignal, Camila Arias, et al.
Respiratory Research (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Recent advances in understanding the role of eosinophils
Gregory Constantine, Amy D. Klion
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 14
Omalizumab may protect allergic patients against COVID-19: A systematic review
Daniele Giovanni Ghiglioni, Laura Cozzi, Riccardo Castagnoli, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100741-100741
Open Access | Times Cited: 8
Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
Eu Jeong Ku, Kee‐Ho Song, Kyoung Min Kim, et al.
Endocrinology and Metabolism (2023) Vol. 38, Iss. 2, pp. 253-259
Open Access | Times Cited: 6
Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection
Francesca Conway, Chloë I. Bloom, Pallav L. Shah
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 206, Iss. 6, pp. 696-703
Open Access | Times Cited: 9
Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database
Yuwei Sun, D. Claire Miller, Idara Akpandak, et al.
Ophthalmology (2022) Vol. 129, Iss. 10, pp. 1096-1106
Open Access | Times Cited: 9
Rethinking Immunological Risk: A Retrospective Cohort Study of Severe SARS-Cov-2 Infections in Individuals With Congenital Immunodeficiencies
Alan A. Nguyen, Saddiq B. Habiballah, Brenna LaBere, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3391-3399.e3
Open Access | Times Cited: 5
COVID-19 and Its Impact on Common Diseases in the Allergy Clinics
Emek Kocatürk, Elissa M. Abrams, Marcus Maurer, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 11, pp. 3289-3303
Closed Access | Times Cited: 5
Asthma and clinical outcomes of COVID-19 in a community setting
Li Jiao, Deborah Bujnowski, Pengfeï Liu, et al.
Public Health (2023) Vol. 226, pp. 84-90
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top